. . . . . . . . . "The on‐label indication for Brintellix is depression; we identified the following off‐label indications: schizophrenia, episodic mood disorders, anxiety disorders, personality disorders, bipolar depression, post‐traumatic stress disorder, and chronic pain." . . . . . . "Adults" . . "2021-08-17T12:40:51.128740"^^ . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" . "CzgYRYv6j0AWe2mFhZSyNrKm8L8qYKsnE9l1ivgvI8dcldt1KMui+rGKlytLNbCCAwK+yTi6oKUB9nw3dHzvzMtkUKe9Gu1TYwc3oy3/O0RaghKhJ2SifdVhJtNjNfpysd/tuqFkQGXUsAko9MqlJ5TWGAUhiAi6T0pR9L/+t/E=" . . "2021-08-17T12:40:51.128740"^^ . . .